受强制性开放获取政策约束的文章 - Kathleen A. Burke了解详情
无法在其他位置公开访问的文章：1 篇
AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia
SB Balachander, SW Criscione, KF Byth, J Cidado, A Adam, P Lewis, ...
Clinical Cancer Research 26 (24), 6535-6549, 2020
强制性开放获取政策： Wellcome Trust
可在其他位置公开访问的文章：32 篇
The genetic landscape of endometrial clear cell carcinomas
DF DeLair, KA Burke, P Selenica, RS Lim, SN Scott, S Middha, ...
The Journal of pathology 243 (2), 230-241, 2017
强制性开放获取政策： US National Institutes of Health
Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results
JC Byrd, WG Wierda, A Schuh, S Devereux, JM Chaves, JR Brown, ...
Blood, The Journal of the American Society of Hematology 135 (15), 1204-1213, 2020
强制性开放获取政策： US National Institutes of Health, Lymphoma Research Foundation, USA
The landscape of somatic genetic alterations in metaplastic breast carcinomas
CKY Ng, S Piscuoglio, FC Geyer, KA Burke, F Pareja, CA Eberle, RS Lim, ...
Clinical cancer research 23 (14), 3859-3870, 2017
强制性开放获取政策： Swiss National Science Foundation, US National Institutes of Health
Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples
LG Martelotto, T Baslan, J Kendall, FC Geyer, KA Burke, L Spraggon, ...
Nature medicine 23 (3), 376-385, 2017
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas
FC Geyer, A Li, AD Papanastasiou, A Smith, P Selenica, KA Burke, ...
Nature communications 9 (1), 1816, 2018
强制性开放获取政策： Swiss National Science Foundation, US National Institutes of Health
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene …
S Piscuoglio, CKY Ng, M Murray, KA Burke, M Edelweiss, FC Geyer, ...
The Journal of pathology 238 (4), 508-518, 2016
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity
S Chiang, B Weigelt, HC Wen, F Pareja, A Raghavendra, LG Martelotto, ...
Cancer research 76 (24), 7118-7129, 2016
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
Second harmonic generation reveals matrix alterations during breast tumor progression
K Burke, P Tang, E Brown
Journal of biomedical optics 18 (3), 031106-031106, 2013
强制性开放获取政策： US National Institutes of Health
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer
X Xu, C De Angelis, KA Burke, A Nardone, H Hu, L Qin, J Veeraraghavan, ...
Clinical Cancer Research 23 (17), 5123-5134, 2017
强制性开放获取政策： US National Institutes of Health
Uterine adenosarcomas are mesenchymal neoplasms
S Piscuoglio, KA Burke, CKY Ng, AD Papanastasiou, FC Geyer, ...
The Journal of pathology 238 (3), 381-388, 2016
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
The Antidepressant Desipramine and α2-Adrenergic Receptor Activation Promote Breast Tumor Progression in Association with Altered Collagen Structure
MJ Szpunar, KA Burke, RP Dawes, EB Brown, KS Madden
Cancer Prevention Research 6 (12), 1262-1272, 2013
强制性开放获取政策： US National Institutes of Health
Compromised BRCA1–PALB2 interaction is associated with breast cancer risk
TK Foo, M Tischkowitz, S Simhadri, T Boshari, N Zayed, KA Burke, ...
Oncogene 36 (29), 4161-4170, 2017
强制性开放获取政策： US National Institutes of Health, European Commission, Susan G. Komen
Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing …
MF Rimawi, C De Angelis, A Contreras, F Pareja, FC Geyer, KA Burke, ...
Breast cancer research and treatment 167, 731-740, 2018
强制性开放获取政策： US Department of Defense, US National Institutes of Health, Susan G. Komen
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer
N Fusco, FC Geyer, MR De Filippo, LG Martelotto, CKY Ng, S Piscuoglio, ...
Modern Pathology 29 (11), 1292-1305, 2016
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
Mutation profiling of key cancer genes in primary breast cancers and their distant metastases
WAME Schrijver, P Selenica, JY Lee, CKY Ng, KA Burke, S Piscuoglio, ...
Cancer research 78 (12), 3112-3121, 2018
强制性开放获取政策： US National Institutes of Health, Dutch Cancer Society
Enzymatically-responsive pro-angiogenic peptide-releasing poly (ethylene glycol) hydrogels promote vascularization in vivo
AH Van Hove, K Burke, E Antonienko, E Brown III, DSW Benoit
Journal of Controlled Release 217, 191-201, 2015
强制性开放获取政策： US National Institutes of Health, Howard Hughes Medical Institute
Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breast
S Piscuoglio, CKY Ng, FC Geyer, KA Burke, CF Cowell, LG Martelotto, ...
NPJ breast cancer 3 (1), 48, 2017
强制性开放获取政策： Swiss National Science Foundation, US National Institutes of Health, Breast …
The genetic landscape of breast carcinomas with neuroendocrine differentiation
C Marchiò, FC Geyer, CKY Ng, S Piscuoglio, MR De Filippo, M Cupo, ...
The Journal of pathology 241 (3), 405-419, 2017
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
Phyllodes tumors with and without fibroadenoma-like areas display distinct genomic features and may evolve through distinct pathways
F Pareja, FC Geyer, R Kumar, P Selenica, S Piscuoglio, CKY Ng, ...
NPJ Breast Cancer 3 (1), 40, 2017
强制性开放获取政策： Swiss National Science Foundation, US National Institutes of Health
出版信息和资助信息由计算机程序自动确定